• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Switzerland·Financial Services·SREN.SW
Share

Swiss Re AG Stocks

CHF 142.85Last Updated 04.09.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

CHF 52.02B

CHF 142.85
Key Takeaways

Risk factor

Strong trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Swiss Re AG, along with its affiliated entities, operates internationally as a prominent provider of diverse risk management solutions. Its offerings extend to wholesale reinsurance, direct insurance products, various forms of insurance-based risk transfer, and associated services. The company's extensive operations are primarily channeled through three key business divisions: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. Specifically, the Property & Casualty Reinsurance unit undertakes the underwriting of a comprehensive array of risks. This includes property-related coverages like general property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative solutions. It also encompasses casualty reinsurance for areas such as general liability, motor vehicle, workers' compensation, personal accident, management and professional liability, and cyber threats, alongside facultative options. The Life & Health Reinsurance segment specializes in underwriting solutions for both life and health insurance portfolios. The Corporate Solutions division provides tailored risk transfer products, ranging from standardized covers and multi-line programs to highly customized insurance solutions for businesses. Its extensive client base spans various sectors, including stock and mutual insurance carriers, government and public bodies, medium to large enterprises, and private individuals. Established in 1863, the company maintains its headquarters in Zurich, Switzerland.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of SREN.SW is 135 and suggests 5.8% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

07.09.2026 14:56

OpenAI's new AI model pushed emerging market stocks to a two-month high

07.09.2026 14:10

Tyra shares are having their best day in 10 months. Investors are awaiting new data on its drug

07.09.2026 13:11

U.S. inflation, Apple's latest products, Oracle's earnings report: What Investors Need to Know This Week

07.09.2026 12:22

Brent surged to $98. U.S. officials said the nuclear deal with Iran might not go through

07.09.2026 10:53

Top Stories This Morning: The U.S. Has Left Open the Possibility of Withdrawing from the Iran Nuclear Deal; Anthropic Has Postponed Its IPO

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026